“It Is What It Is” (age 13) JCO Art of Oncology series Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, February 16, 2016

“It Is What It Is” (age 13) JCO Art of Oncology series



“It Is What It Is”

 Presymptomatic DNA testing has introduced a new category of patients—those who do not have cancer but are at increased risk. They have been through the process of making a decision about DNA testing. When at risk, they may opt for surveillance, preventive surgery, or other ways to reduce their risk. Their frame of reference may be well known, as in BRCA; it may be less familiar, as in Lynch syndrome; or it may be obscure, as in HLRCC.
 A looming challenge for the field is to provide adequate guidance based on evidence, resources, and, most importantly, the preferences of the patient.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.